Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and molecular perspective

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 267-274

  Gillespie, Stephen H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; PENICILLIN DERIVATIVE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TUBERCULOSTATIC AGENT;

ADAPTATION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL GENETICS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SHORT SURVEY; TUBERCULOSIS;

ADAPTATION, BIOLOGICAL; DRUG RESISTANCE, BACTERIAL; EVOLUTION; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; STREPTOMYCIN;

EID: 0036150240     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.267-274.2002     Document Type: Short Survey

References (86)

1. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods
2. Tubercle bacilli resistant to isoniazid: Virulence and response to treatment with isoniazid in guinea pigs and mice
3. Virulence of antibiotic-resistant Salmonella typhimurium
4. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
5. Fitness of antibiotic-resistant microorganisms and compensatory mutations
6. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital
7. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin
8. Direct bacteriologic study of treated tuberculomas
9. Some comparative aspects of rifampicin and isoniazid
10. A link between streptomycin and rifampicin mutation
11. Interaction between mutations of ribosomes and RNA polymerase: A pair of strA and rif mutants individually temperature-insensitive but temperature-sensitive in combination
12. USPHS tuberculosis short-course chemotherapy trial 21: Effectiveness, toxicity, and acceptability. The report of final results
13. Streptomycin resistance in pulmonary tuberculosis
14. Mobile genetic elements in mycobacteria
15. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis
16. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment
17. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis
18. Die behandlung der tuberkulose mit neoteben (isonikotinsaurehydrazid)
19. Mutant prevention concentration as a measure of antibiotic potency: Studies with clinical isolates of Mycobacterium tuberculosis
20. Ethambutol in the initial treatment of pulmonary tuberculosis
21. The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes
22. DNA gyrase, topoisomerase IV, and the 4-quinolones
23. Tuberculosis 2000-2010: Control, but not elimination
24. Will tuberculosis become resistant to all antibiotics?
25. Controlled trial of five short course regimens of chemotherapy regimens for pulmonary tuberculosis
26. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome
27. Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema
28. Ethambutol: A substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis
29. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection
30. The current status of short course chemotherapy
31. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications
32. The antibacterial activity of rifamycins
33. Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: Cortisone test
34. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis
35. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis
36. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis
37. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
38. Resistance to isonicotinic acid
39. Streptomycin resistance in mycobacteria
40. Contrasting evolutionary rates in the duplicate chaparonin genes of Mycobacterium tuberculosis and M. leprae
41. Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance
42. The early bactericidal activity of drugs in patients with pulmonary tuberculosis
43. Luria-Delbruck fluctuation experiments: Design and analysis
44. Genetic antagonism and hypermutability in Mycobacterium smegmatis
45. Para-aminosalacylic acid in the treatment of tuberculosis
46. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA
47. Population dynamics of tuberculosis treatment: Mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance
48. Mutations of bacteria from virus sensitivity to virus resistance
49. Antimicrobial therapy of pulmonary tuberculosis
50. The effect of nicotinic acid amide on experimental tuberculosis of white mice
51. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
52. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis
53. Clinical evaluation of isoniazid
54. The segregation of streptomycin resistant variants of Mycobacterium tuberculosis into groups with characteristic resistance
55. The action of antituberculosis drugs in short-course chemotherapy
56. Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv
57. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York
58. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
59. Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000
60. Global surveillance for antituberculosis-drug resistance, 1994-1997
61. In vitro studies on isonicotinic acid hydrazine
62. Relative numbers of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin
63. The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance to isoniazid
64. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 Update
65. Risk factors for rifampin mono-resistant tuberculosis
66. Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples
67. Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: A low-cost, rapid approach
68. Effect of streptomycin and other antibioic substances upon Mycobacterium tuberculosis and related organisms
69. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
70. Drug resistance in tuberculosis control
71. Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria
72. The neglected global tuberculosis problem: A report of the 1992 World Congress on Tuberculosis
73. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities
74. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities
75. Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations
76. Fluctuation analysis: The probability distribution of the number of mutants under different conditions
77. Bacterial resistance studies with derivatives of isonicotinic acid
78. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
79. The demonstration of naturally occurring streptomycin resistant variants in the human strain of tubercule bacillus H-37RV
80. The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901
81. Dormancy of Mycobacterium tuberculosis and latency of disease
82. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
83. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations
84. Selection of antibiotic-resistant bacterial mutants: Allelic diversity among fluoroquinolone-resistant mutations